LIFECORE BIOMEDICAL, INC. \DE\ Income Statement
LFCR|8 years of annual SEC 10-K data (FY2012-FY2019)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
LIFECORE BIOMEDICAL, INC. \DE\ reported $524M in revenue and $11M in net income for FY2019. Revenue has grown at a 11.9% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $524.2M | $476.9M | $539.3M | $476.8M | $441.7M | $317.6M | $276.7M | $238.2M |
| Cost of Revenue | $390.6M | $410.1M | $473.9M | $414.2M | $378.9M | $265.4M | $230.0M | $204.5M |
| Gross Profit | $79.2M | $66.8M | $14.2M | $62.6M | $62.8M | $52.1M | $46.7M | $33.8M |
| SG&A Expense | $52.5M | $46.2M | $40.0M | $35.2M | $32.5M | $26.5M | $24.6M | $17.7M |
| R&D Expense | $9.5M | $7.2M | $7.0M | $7.2M | $9.3M | $9.6M | $9.3M | $4.4M |
| Operating Income | $14.7M | -$20.6M | $18.5M | $20.2M | $24.9M | $14.6M | $8.0M | $8.0M |
| Interest Expense | - | - | - | $1.6M | $2.0M | $929.0K | $820.0K | $88.0K |
| Income Tax | $4.0M | -$7.7M | $7.7M | $10.6M | $9.5M | $7.2M | $4.2M | -$4.3M |
| Net Income | $10.6M | -$11.6M | $2.4M | $19.1M | $22.6M | $12.7M | $3.9M | $4.0M |
| EPS (Basic) | $0.39 | -$0.43 | $0.09 | $0.72 | $0.87 | $0.49 | $0.15 | $0.15 |
| EPS (Diluted) | $0.38 | -$0.43 | $0.09 | $0.71 | $0.85 | $0.49 | $0.15 | $0.15 |
| Shares Outstanding | 27.7M | 27.5M | 27.1M | 27.0M | 26.8M | 26.4M | 25.6M | 26.4M |
| Gross Margin | 15.1% | 14.0% | 2.6% | 13.1% | 14.2% | 16.4% | 16.9% | 14.2% |
| Operating Margin | 2.8% | -4.3% | 3.4% | 4.2% | 5.6% | 4.6% | 2.9% | 3.4% |
| Profit Margin | 2.0% | -2.4% | 0.4% | 4.0% | 5.1% | 4.0% | 1.4% | 1.7% |